June 15, 2020 Price forecast | 2 weeks: 0.45% | 1 month: -5.17% | 3 months: -9.61%

AXDX stock forecast

Our latest prediction for Accelerate Diagnostics, Inc.'s stock price was made on the June 15, 2020 when the stock price was at 10.10$.

In the short term (2weeks), AXDX's stock price should outperform the market by 0.45%. During that period the price should oscillate between -10.33% and +12.70%.

In the medium term (3months), AXDX's stock price should underperform the market by -9.61%. During that period the price should oscillate between -41.26% and +26.08%.

Create a solid portfolio with AXDX

Add AXDX to your portfolio and optimize it!

About Accelerate Diagnostics, Inc.

Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. Its products include Accelerate Pheno and Accelerate PhenoTest. The company was founded on May 26, 1982 and is headquartered in Tucson, AZ.

At the moment the company generates 10M USD in revenues.

On its last earning announcement, the company reported a loss of -1.54$ per share.

The book value per share is 1.75$

Accelerate Diagnostics, Inc. website

Three months stock forecastJune 15, 2020


Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
10M 46.70% -72M -725.40% -84M -1.54 - - 55M 1.75 -63M -1M -64M